Literature DB >> 10901269

Phosphorylation of tau alters its association with the plasma membrane.

F J Ekinci1, T B Shea.   

Abstract

1. The potential functions of the microtubule-associated protein tau have been expanded by the recent demonstration of its interaction with the plasma membrane. Since the association of tau with microtubules is regulated by phosphorylation, herein we examine whether or not the association of tau with the plasma membrane is also regulated by phosphorylation. 2. A range of tau isoforms migrating from 46 to 64 kDa was associated with crude particulate fractions derived from SH-SY-5Y human neuroblastoma cells, and were retained during the initial stages of plasma membrane purification. During the extensive washing utilized in purification of the plasma membrane, portions of each of these isoforms were depleted from the resultant purified membrane. Immunoblot analysis with phospho-dependent and -independent antibodies revealed selective depletion of phospho isoforms during membrane washing. This effect was more pronounced for the slowest-migrating (64-kDa) tau isoform. 3. This putative influence of phosphorylation on the association of tau with the plasma membrane was further probed by transfection of SH-SY-5Y human neuroblastoma cells with a tau construct that could associate with the plasma membrane but not with microtubules. Treatment with phorbol ester or calcium ionophore, both of which increased phospho-tau levels within the cytosol and plasma membrane, was accompanied by the dissociation of this tau construct from the membrane. 4. These data indicate that phosphorylation regulates the association with the plasma membrane. Dissociation from the membrane by phosphorylation may place tau at risk for hyperphosphorylation and ultimate PHF formation in a manner previously considered for tau dissociated from microtubules.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10901269     DOI: 10.1023/a:1007075115574

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  54 in total

1.  The effect of tau antisense oligonucleotides on neurite formation of cultured cerebellar macroneurons.

Authors:  A Caceres; S Potrebic; K S Kosik
Journal:  J Neurosci       Date:  1991-06       Impact factor: 6.167

2.  The microtubule binding domain of tau protein.

Authors:  G Lee; R L Neve; K S Kosik
Journal:  Neuron       Date:  1989-06       Impact factor: 17.173

3.  Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5.

Authors:  A Sengupta; Q Wu; I Grundke-Iqbal; K Iqbal; T J Singh
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

4.  Amyloid beta protein potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels: a possible involvement of free radicals.

Authors:  K Ueda; S Shinohara; T Yagami; K Asakura; K Kawasaki
Journal:  J Neurochem       Date:  1997-01       Impact factor: 5.372

5.  Respective roles of neurofilaments, microtubules, MAP1B, and tau in neurite outgrowth and stabilization.

Authors:  T B Shea; M L Beermann
Journal:  Mol Biol Cell       Date:  1994-08       Impact factor: 4.138

6.  Phosphorylation, calpain proteolysis and tubulin binding of recombinant human tau isoforms.

Authors:  J M Litersky; C W Scott; G V Johnson
Journal:  Brain Res       Date:  1993-02-26       Impact factor: 3.252

7.  Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments.

Authors:  L S Yang; H Ksiezak-Reding
Journal:  Eur J Biochem       Date:  1995-10-01

8.  Rapid Alzheimer-like phosphorylation of tau by the synergistic actions of non-proline-dependent protein kinases and GSK-3.

Authors:  T J Singh; N Haque; I Grundke-Iqbal; K Iqbal
Journal:  FEBS Lett       Date:  1995-01-30       Impact factor: 4.124

9.  Phosphorylation of microtubule-associated protein tau: identification of the site for Ca2(+)-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles.

Authors:  B Steiner; E M Mandelkow; J Biernat; N Gustke; H E Meyer; B Schmidt; G Mieskes; H D Söling; D Drechsel; M W Kirschner; M Goedert; E Mandelkow
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

10.  Tau protein function in living cells.

Authors:  D G Drubin; M W Kirschner
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  7 in total

Review 1.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

Review 2.  Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies.

Authors:  Einar M Sigurdsson
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

3.  Acetyl-L-carnitine protects against amyloid-beta neurotoxicity: roles of oxidative buffering and ATP levels.

Authors:  Sirakarnt Dhitavat; Daniela Ortiz; Thomas B Shea; Ezequiel R Rivera
Journal:  Neurochem Res       Date:  2002-06       Impact factor: 3.996

4.  Discovery and characterization of stable and toxic Tau/phospholipid oligomeric complexes.

Authors:  Nadine Ait-Bouziad; Guohua Lv; Anne-Laure Mahul-Mellier; Shifeng Xiao; Gizem Zorludemir; David Eliezer; Thomas Walz; Hilal A Lashuel
Journal:  Nat Commun       Date:  2017-11-22       Impact factor: 14.919

5.  The importance of tau phosphorylation for neurodegenerative diseases.

Authors:  Wendy Noble; Diane P Hanger; Christopher C J Miller; Simon Lovestone
Journal:  Front Neurol       Date:  2013-07-01       Impact factor: 4.003

6.  The role of tau in neurodegeneration.

Authors:  Tania F Gendron; Leonard Petrucelli
Journal:  Mol Neurodegener       Date:  2009-03-11       Impact factor: 14.195

7.  Ectosomes: a new mechanism for non-exosomal secretion of tau protein.

Authors:  Simon Dujardin; Séverine Bégard; Raphaëlle Caillierez; Cédrick Lachaud; Lucie Delattre; Sébastien Carrier; Anne Loyens; Marie-Christine Galas; Luc Bousset; Ronald Melki; Gwennaëlle Aurégan; Philippe Hantraye; Emmanuel Brouillet; Luc Buée; Morvane Colin
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.